Home

Terumo Corp (TRUMF)

16.72
+2.05 (13.97%)
OP · Last Trade: Oct 31st, 11:54 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close14.67
Open14.83
Bid-
Ask-
Day's Range14.83 - 17.31
52 Week Range14.47 - 22.26
Volume1,499
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume13,867

Chart

News & Press Releases

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analystbenzinga.com
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via Benzinga · January 23, 2024